Glenmark’s consolidated revenue rises to Rs 27,674.89 million for Q4 FY 2019-20
Consolidated net profit was at Rs 2203.08 million for the quarter ended March 31, 2019
Glenmark Pharmaceuticals, a research-led…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
EBITDA
Sun Pharma posts Q3FY20 gross sales at Rs 8,039 crores
In Q3, the company registered a net profit of Rs 914 crores
Sun Pharmaceutical Industries reported financials for the third…
Strides posts consolidated revenue at ₹7,353 m in Q3FY20
Consolidated EBITDA was at ₹1,851 million
Strides Pharma Science has announced its Q3FY20 results. In Q3FY20, the consolidated…
Biocon sees revenue growth of 14 per cent to Rs 1,784 crores in Q3FY20
EBITDA at Rs 480 crores, up 18 per cent
Syngene reports 11 per cent revenue growth in Q3 to Rs 539 crores
EBITDA up 10 per cent to Rs 173 crores; the company also separates the roles of managing director and chairperson
Lonza seeks drug industry veteran as CEO to sharpen pharma focus
Net profit last year was 646 million francs versus 563 million in 2018, the Basel-based company said. Sales rose 6.8 per cent to…
UFlex closes Q2 of FY19-20 with EBITDA of 279 cr
The total production volume of the company during the quarter was 94218 MT as compared to 102442 MT during Sept 2018 quarter and…
Ajanta Pharma’s total comprehensive income dips by 23% in Q1 FY 2018
Company posted profit after tax at Rs. 95 crores
DRL posts Q2 FY17 and H1FY17 results
In Q2 FY17, EBITDA is at Rs 6.4 billion and profit after tax at Rs 2.9 billion
Ajanta Pharma posts Q4 and FY 2016 results
Revenue from operations grew 14 per cent at Rs 426 crores against Rs 372 crores in Q4 FY 2016